R&D
Upper Respiratory Tract Infection (URTI) & Immune Enhancement. Based on Coree proprietary strain-safe bacterial lysates, completed human cell model immune stimulation validation and mouse influenza A virus challenge protection experiments. Stage: Laboratory & Preclinical.
Milestones 2026-2030: In vivo POC → Toxicity Study → Clinical Study → OTC Registration → Market Launch.
Supporting infant intestinal immunity and brain development. Producing oligosaccharides through microbial fermentation of natural food sources, reducing biological rejection risk. Completed in-vitro prebiotic effect validation. Stage: Laboratory research.
2026-2030 Milestones: In-vivo functional POC → Formula development → Clinical study → Functional food registration → Market launch.
Metagenomic/metabolomic analysis for Type 2 diabetes and/or obesity patients to discover microbial biomarkers. In collaboration with Gemelli Hospital, Italy, led by Prof. Antonio Gasbarrini (National Coordinator of the Italian Society of Gastroenterology Gut Microbiota Study Group). Completed salivary and fecal microbiome analysis. Stage: Omics analysis.
Milestones 2026-2030: Candidate Screening → Product Discovery → In vivo Toxicity → Clinical Study → Market Launch.
Addressing digestive issues such as diarrhea and allergic reactions during infant weaning. Stage: Pilot study.
2026-2030 Milestones: Formula development → Functional food clinical study → Registration → Market launch → Adult market expansion.
Synbiotic probiotics, enhancing intestinal health and improving dysbiosis. Stage: Formula research.
2026-2030 Milestones: Formula development → Functional food clinical study → Registration → Market launch.
Commercialized Strains (5)
(anti-pathogen, antioxidant)
(blood sugar regulation)
(immune support)
(immune support + weight management)
(oral pathogen inhibition)
Strains in Development (6)
(anti-inflammatory + intestinal barrier)
(skin probiotic)
(anti-inflammatory + antioxidant + constipation relief)
(postbiotic immune enhancement + GLP-1 secretion)
(weight management)
(blood sugar regulation + weight management)
Strains in Research (4)
(immune support)
(skin anti-inflammatory)
(oral pathogen inhibition)
(body fat reduction)
China/Korea/Europe
/U.S./PCT
Europe/U.S./China
/Korea
China, including microemulsion vaccine delivery system patent in collaboration with Sichuan University
European frontier microbiome and nutritional science research base, equipped with advanced omics analysis platform, in deep collaboration with Gemelli Hospital
Clinical collaboration platform supporting microbiome, metabolomics and nutritional intervention studies with leading gastroenterology research resources in Italy.
University research partnership connecting strain discovery, functional validation and nutrition science to Coree's broader R&D and commercialization pipeline.
License Coree validated strains, formulas, or production processes for rapid productization
Co-invest R&D resources, share IP and commercialization outcomes
Equity investment or outright acquisition of mature pipelines
Preclinical research, formula optimization, stability testing, and other R&D services for external enterprises